English | 简体中文 | 繁體中文 | 한국어 | 日本語
  Press Releases
Friday, March 29, 2024
乐普生物2023年收入快速增长,亏损大幅收窄,ADC进入收获期
樂普生物2023年收入快速增長,虧損大幅收窄,ADC進入收穫期
Friday, August 25, 2023
乐普生物公布2023年中期业绩
樂普生物公佈2023年中期業績
Friday, March 17, 2023
乐普生物公布2022年度业绩
樂普生物公佈2022年度業績
Thursday, February 23, 2023
乐普生物和康诺亚共同宣布与阿斯利康就CMG901达成全球独家授权协议
樂普生物和康諾亞共同宣佈與阿斯利康就CMG901達成全球獨家授權協定
Lepu Biopharma and Keymed Jointly Announces Global Exclusive Licence Agreement with AstraZeneca for CMG901
Thursday, September 29, 2022
乐普生物PD-1单抗普佑恒(TM)获批新适应症,MRG003获CDE纳入突破性治疗药物名单

Copyright © 2024 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575